Loading...

LIMN LIMINATUS PHARMA INC Delisting Actions 8-K Filing

LMNT

LMN

LIMINATUS PHARMA INC

(LIMN)

2026 8-K

Bylaw Amendment

Stock Offering Details

Settlement Agreement

Delisting Notice

Nasdaq Non-Compliance

Nasdaq Non-Compliance

Research Update

Investor Meetings

Non-Compliance Notification

Merger of Equals

Merger of Equals

External Links:

On January 15, 2026, Liminatus Pharma, Inc. received a notice from Nasdaq indicating it did not meet the minimum bid price of $1 per share, with a 180-day compliance period to regain it.

AI Assistant

LIMINATUS PHARMA INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.